至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models

Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2018-12; 
Zhang W, Ahmad G, Molehin AJ, Torben W, Le L, Kim E, Lazarus S, Siddiqui AJ, Carter D, Siddiqui AA
Products/Services Used Details Operation
Plasmid DNA Preparation brief, the full length Sm-p80 gene cloned into pCold II (GenScript Corp Get A Quote

摘要

关键词